Literature DB >> 19064325

Simultaneous occurrence of facial fibrous dysplasia and ameloblastoma.

Mustafa Keskin1, Furkan E Karabekmez, Birkan T Ozkan, Zekeriya Tosun, Mustafa C Avunduk, Nedim Savaci.   

Abstract

BACKGROUND: Both fibrous dysplasia (FD) and ameloblastoma are benign but locally aggressive tumours of the craniofacial region. In this case report, we present the unique synchronous occurrence of these two tumours in the facial skeleton. CASE REPORT: A 16-year-old woman presented with complaints of swelling of the upper right face and at the inferior border of the mandible. She was diagnosed as FD of the maxilla, temporal bone and sphenoid sinus together with ameloblastoma of the mandible after surgery and histopathological evaluation.
CONCLUSION: The case that we present here is unique in that two separate pathological conditions, FD of the upper face, and ameloblastoma of the mandible coexisted. Although cases of synchronous or metachronous occurrence of FD and ameloblastoma with other pathology have been previously described, this to our knowledge, is the first reported case of true coexistence of FD and ameloblastoma.

Entities:  

Mesh:

Year:  2008        PMID: 19064325     DOI: 10.1016/j.jcms.2008.10.015

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  3 in total

1.  Craniofacial fibrous dysplasia: Surgery and literature review.

Authors:  Suresh Menon; Srihari Venkatswamy; Veena Ramu; Khurshida Banu; Sham Ehtaih; Vinay M Kashyap
Journal:  Ann Maxillofac Surg       Date:  2013-01

2.  Recurrent Monostotic Fibrous Dysplasia in the Mandible.

Authors:  Nilton Alves; Reinaldo José de Oliveira; Denise Takehana; Naira Figueiredo Deana
Journal:  Case Rep Dent       Date:  2016-05-31

Review 3.  Different clinical presentation and management of temporal bone fibrous dysplasia in children.

Authors:  Józef Mierzwiński; Justyna Kosowska; Justyna Tyra; Karolina Haber; Maria Drela; Dariusz Paczkowski; Paweł Burduk
Journal:  World J Surg Oncol       Date:  2018-01-15       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.